NCT05335993 2025-07-10
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
CanariaBio Inc.
Phase 2 Active not recruiting
Clinical Trials
7 trialsNCT04498117 2025-07-09
FLORA-5
CanariaBio Inc.
Phase 3 Active not recruiting
NCT03100006 2022-06-13
ORION-01
National Cancer Centre, Singapore
Phase 1/2 Terminated
NCT04620954 2021-12-01
ORION-02
National Cancer Centre, Singapore
Phase 1/2 Unknown
NCT00003634 2013-11-06
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00004064 2013-11-06
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00034138 2007-12-18
A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma
Unither Pharmaceuticals
Phase 1/2 Terminated